Cough, Cold and Allergy (hay Fever) Remedies in Mexico

Publication Date	September 2009
Publisher	Euromonitor
Product Type	Report
Pages	44
ISBN Number	not applicable
Product Code	EUR00724

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Cough, Cold and Allergy Products in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, child-specific products, antihistamines

Data coverage:

market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

Get a detailed picture of the cough, cold and allergy (hayfever) industry
Identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content

Cough, Cold and Allergy (hay Fever) Remedies in Mexico
Euromonitor International
September 2009
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
- Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
- Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
- Table 3 Sales of Decongestants by Type: Value 2003-2008
- Table 4 Sales of Decongestants by Type: % Value Growth 2003-2008
- Table 5 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
- Table 6 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
- Table 7 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
- Table 8 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
- Table 9 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
- Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
- Table 11 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
Bayer De México SA De Cv
Strategic Direction
Key Facts
- Summary1 Bayer de México SA de CV: Key Facts
- Summary2 Bayer de México SA de CV: Operational Indicators
Company Background
Production
- Summary3 Bayer de México SA de CV: Production Statistics 2007
Competitive Positioning
- Summary4 Bayer de México SA de CV: Competitive Position 2008
Boehringer Ingelheim Promeco SA De Cv
Strategic Direction
Key Facts
- Summary5 Boehringer Ingelheim Promeco SA de CV: Key Facts
- Summary6 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary7 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2008
Farmacias Similares SA De Cv
Strategic Direction
Key Facts
- Summary8 Farmacias Similares SA de CV: Key Facts
- Summary9 Farmacias Similares SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary10 Farmacias Similares SA de CV: Competitive Position 2008
Genomma Lab SA De Cv
Strategic Direction
Key Facts
- Summary11 Genomma Lab SA de CV: Key Facts
- Summary12 Genomma Lab SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary13 Genomma Lab SA de CV: Competitive Position 2008
GlaxoSmithKline Plc
Strategic Direction
Key Facts
- Summary14 GlaxoSmithKline México SA de CV: Key Facts
- Summary15 GlaxoSmithKline México SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary16 GlaxoSmithKline México SA de CV: Competitive Position 2008
Merck-méxico SA
Strategic Direction
Key Facts
- Summary17 Merck-México SA: Key Facts
- Summary18 Merck-México SA: Operational Indicators
Company Background
Competitive Positioning
- Summary19 Merck-México SA: Competitive Position 2008
Novartis Farmacéutica SA De Cv
Strategic Direction
Key Facts
- Summary20 Novartis Farmacéutica SA de CV: Key Facts
- Summary21 Novartis Farmacéutica SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary22 Novartis Farmacéutica SA de CV: Competitive Position 2008
Pfizer SA De Cv
Strategic Direction
Key Facts
- Summary23 Pfizer SA de CV: Key Facts
- Summary24 Pfizer SA de CV: Operational Indicators
Company Background
Competitive Positioning
- Summary25 Pfizer SA de CV: Competitive Position 2008
Procter & Gamble De México SA De Cv
Strategic Direction
Key Facts
- Summary26 Procter & Gamble de México SA de CV: Key Facts
- Summary27 Procter & Gamble de México SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
- Summary28 Procter & Gamble de México SA de CV: Competitive Position 2008
Wyeth SA De Cv
Strategic Direction
Key Facts
- Summary29 Wyeth SA de CV: Key Facts
- Summary30 Wyeth SA de CV: Operational Indicators
Company Background
Production
- Summary31 Wyeth SA de CV: Production Statistics 2007
Competitive Positioning
- Summary32 Wyeth SA de CV: Competitive Position 2008
Executive Summary
Sales of OTC Medication Grow at A Lower Pace
Mexican Regulations May Cause Abrupt Changes
Many Leading Positions Threatened by Emerging Industry Giant
Chained Outlets Are Taking Over the Distribution of Medications
Modest Growth Ahead
Key Trends and Developments
Mexican Regulation Seeking Quality and Affordability in Medications
Mexicans Like To Self-medicate
the Pharmaceutical Industry Faces Cost Pressures
Large Distributors of Medications Are Expanding Throughout Mexico
A Giant Is Making the OTC Industry Tremble
Market Indicators
- Table 12 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 13 Life Expectancy at Birth 2003-2008
Market Data
- Table 14 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 15 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 16 OTC Healthcare Company Shares by Value 2004-2008
- Table 17 OTC Healthcare Brand Shares by Value 2005-2008
- Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 20 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 21 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
- Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Definitions
- Summary33 Research Sources